News

News from The American Academy of Ophthalmology

• Lower Atropine Doses May Have a Modest Effect on Progression in Low Myopia and Pre-Myopia
  Compared with placebo, treatment with atropine 0.01% led to slower myopia progression in younger school-age children with low or pre-myopia, but this effect was not significant.
• Weekly Journal Update — January 28, 2026
  Vitrectomy with ILM peeling for grade C PVR, glaucoma and dementia, metformin use and AMD, sleep insufficiency and retinal neurodegeneration, comparing AI models for ophthalmology case diagnosis.
• Deep Learning Technology Could Help Clinicians Diagnose TED and Orbital Myositis
  A deep learning model, based on computed tomography images, was able to accurately distinguish thyroid eye disease (TED) from orbital myositis.
• Earlier Plasma Exchange Could Yield Better Outcomes in MOGAD
  When initiating plasma exchange for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) attacks, faster treatment may improve the chances of meaningful improvement.
• Cenegermin Shows Real-World Efficacy for Refractory Neurotrophic Keratopathy
  A single-center study saw efficacy of cenegermin for neurotrophic keratopathy across a range of disease stages and etiologies, but the drug appeared to be especially successful in eyes with more severe disease.
• Top ONE Network Videos of 2025
  From a method of assessing visual acuity in younger children to fixing a case of intraoperative floppy iris syndrome, here’s a look at 2025’s most popular 1-Minute Videos, Surgical Videos, Basic Skills Videos, and Interviews.
• Top ONE Network Editors' Choice Reviews of 2025
  The top 15 Editors’ Choice reviews in 2025 include sodium bicarbonate for reducing acetazolamide side effects, risk of retinal detachment with pilocarpine drops, a nonultrasonic lens extractor for cataracts, and a variety of updates from major journals across ophthalmology.
• Weekly Journal Update — January 21, 2026
  First-line SLT vs eyedrops for glaucoma, initial anti-VEGF injection frequency and nAMD, low vitamin D and risk of proliferative vitreoretinopathy, refractive performance of two light-adjustable lenses, prolonged daylight exposure and risk of POAG.
• Corneal Endothelial Cell Therapy May Be an Option for Treating Corneal Edema
  Injection of a Rho-associated protein kinase (ROCK) inhibitor and cultured corneal endothelial cells could offer a nonsurgical alternative to corneal transplantation.
• Chlorhexidine May Have Advantages Over Povidone-Iodine for Pre-Injection Antisepsis
  Chlorhexidine and povidone-iodine appear to be associated with similar rates of postinjection endophthalmitis, but chlorhexidine might have a more favorable pain and safety profile.